GENETIC POLYMORPHISM OF HUMAN COMPLEMENT PROTEINSHAUPTMANN G.1979; REV. FR. TRANSFUS. IMMUNO. HEMATOL.; FRA; DA. 1979; VOL. 22; NO 5; PP. 587-614; ABS. FRE; BIBL. 107 REF.Article

THE C5B-6 COMPLEX: REACTION WITH C7, C8, C9.PODACK ER; BIESECKER G; KOLB WP et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 2; PP. 484-490; BIBL. 32 REF.Article

THE UNACTIVATED FORM OF THE FIRST COMPONENT OF HUMAN COMPLEMENT, C1.GIGLI I; PORTER RR; SIM RB et al.1976; BIOCHEM. J.; G.B.; DA. 1976; PP. 541-548; H.T. 2; BIBL. 19 REF.Article

STRUCTURE AND ACTIVATION OF THE EARLY COMPONENTS OF COMPLEMENT.PORTER RR.1977; FEDER. PROC.; U.S.A.; DA. 1977; VOL. 36; NO 9; PP. 2191-2196; BIBL. 48 REF.Article

INACTIVATION DU COMPLEMENT PAR LA SALIVE DE SOURIS: DEGRADATION ENZYMATIQUE DE C2, C3, C4, C5 ET C7LECA GERALD.1978; ; FRA; DA. 1978; 58 P.: ILL.; 30 CM; BIBL. 5 P.; TH. UNIV.: SC./PARIS 6/1978Thesis

INACTIVATION OF COMPLEMENT BY MOUSE SALIVA ENZYMATIC DEGRADATION OF C2, C3, C4, C5, AND C7WEILL JC; LECA G; GIRARD JF et al.1979; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1979; VOL. 12; NO 4; PP. 425-435; BIBL. 22 REF.Article

IL-22 : A critical mediator in mucosal host defenseAUJLA, S. J; KOLLS, J. K.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 5, pp 451-454, issn 0946-2716, 4 p.Article

GINGIVAL FLUID ANS SERUM IN PERIODANTAL DISEASES. II. EVIDENCE FOR CLEAVAGE OF COMPLEMENT COMPONENTS C₃, C₃ PROACTIVATOR (FACTOR B) AND C₄ IN GINGIVAL FLUID.SCHENKEIN HA; GENCO RJ.1977; J. PERIODONTOL.; U.S.A.; DA. 1977; VOL. 48; NO 12; PP. 778-784; BIBL. 34 REF.Article

FACTEURS DU COMPLEMENT DANS LE LUPUS ERYTHEMATEUX DISSEMINE.RODRIGO J; GUARDIA J; CABRE VERDIELL J et al.1977; LYON MED.; FR.; DA. 1977; VOL. 238; NO 17; PP. 303-305; ABS. ANGL.; BIBL. 7 REF.Article

KOMPLEMENTSPIEGEL BEI KINDERN MIT IDIOPATHISCH-NEPHROTISCHEM SYNDROM. (C3, C4 UND C3-AKTIVATOR). = LE TAUX DU COMPLEMENT CHEZ LES ENFANTS PRESENTANT UN SYNDROME NEPHROTIQUE IDIOPATHIQUE (C₃, C₄ ET ACTIVATEUR C₃)POLZ E; LUBEC G.1977; PAEDIATR. U. PAEDOL.; OESTERR.; DA. 1977; VOL. 12; NO 4; PP. 360-364; ABS. ANGL.; BIBL. 12 REF.Article

CLINICAL APPLICATIONS OF IMMUNOFIXATION: DETECTION AND QUANTITATION OF COMPLEMENT ACTIVATIONWHICHER JT; HIGGINSON J; RICHES PG et al.1980; J. CLIN. PATHOL.; ISSN 0021-9746; USA; DA. 1980; VOL. 33; NO 8; PP. 781-785; BIBL. 19 REF.Article

BIOSYNTHESIS OF THE COMPLEMENT COMPONENTS AND THE REGULATORY PROTEINS OF THE ALTERNATIVE COMPLEMENT PATHWAY BY HUMAN PERIPHERAL BLOOD MONOCYTESWHALEY K.1980; J. EXPER. MED.; USA; DA. 1980; VOL. 151; NO 3; PP. 501-506; BIBL. 3 P.Article

DEMONSTRATION AND QUANTITATION OF ACTIVATION OF THE FIRST COMPONENT OF COMPLEMENT IN HUMAN SERUM.ZICCARDI RJ; COOPER NR.1978; J. EXPER. MED.; U.S.A.; DA. 1978; VOL. 147; NO 2; PP. 385-395; BIBL. 1 P.Article

FUNCTIONAL AND BIOCHEMICAL PROPERTIES OF THE EARLY CLASSICAL COMPLEMENT SYSTEM OF MICE.GOLDMAN MB; BANGALORE S; GOLDMAN JN et al.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 1; PP. 216-224; BIBL. 20 REF.Article

UNIQUE ROLE OF THE COMPLEMENT RECEPTOR CR₁ IN THE DEGRADATION OF C3B ASSOCIATED WITH IMMUNE COMPLEXESMEDOF M; IIDA K; MOLD C et al.1982; JOURNAL OF EXPERIMENTAL MEDICINE; ISSN 0022-1007; USA; DA. 1982; VOL. 166; NO 6; PP. 1739-1754; BIBL. 48 REF.Article

MODULATION OF THE CLASSICAL PATHWAY C3 CONVERTASE BY PLASMA PROTEINS C4 BINDING PROTEIN AND C3B INACTIVATORGIGLI I; FUJITA T; NUSSENZWEIG V et al.1979; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1979; VOL. 76; NO 12; PP. 6596-6600; BIBL. 33 REF.Article

A SIMPLE METHOD FOR ISOLATING SPECIFIC ANTIBODIES TO COMPLEMENT COMPONENTSSUCHARIT BHAKDI; KAYSER W.1981; J. IMMUNOL. METHODS; ISSN 0022-1759; NLD; DA. 1981; VOL. 41; NO 3; PP. 365-376; BIBL. 16 REF.Article

THE ROLE OF C1S, C1R AND PROPERDIN IN THE INITIATION OF THE C3B-DEPENDENT FEEDBACK MECHANISM OF THE COMPLEMENT SYSTEM.JOHNSON U.1978; ACTA PATHOL. MICROBIOL. SCAND., C; DNK; DA. 1978; VOL. 86; NO 2; PP. 73-78; BIBL. 23 REF.Article

STUDIES ON THE PRECURSOR FORM OF THE FIRST COMPONENT OF COMPLEMENT. I. ISOLATION OF THE PROENZYME FORMS OF C1R AND C1S.CHAPUIS RM; ISLIKER H; ASSIMEH SN et al.1977; IMMUNOCHEMISTRY; G.B.; DA. 1977; VOL. 14; NO 5; PP. 313-317; BIBL. 13 REF.Article

C3 REQUIREMENTS FOR FORMATION OF ALTERNATIVE PATHWAY C5 CONVERTASE.DAHA MR; FEARON DT; AUSTEN KF et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 2; PP. 630-634; BIBL. 23 REF.Article

ACTIVITY OF THE ALTERNATIVE PATHWAY OF COMPLEMENT IN THE NEWBORN INFANTADAMKIN D; STITZEL A; URMSON J et al.1978; J. PEDIATR.; USA; DA. 1978; VOL. 93; NO 4; PP. 604-608; BIBL. 24 REF.Article

A SIMPLIFIED PROCEDURE FOR THE PURIFICATION OF C1-INACTIVATOR FROM HUMAN PLASMA. INTERACTION WITH COMPLEMENT SUBCOMPONENTS C1R AND C1S.REBOUL A; ARLAUD GJ; SIM RB et al.1977; F.E.B.S. LETTERS; NETHERL.; DA. 1977; VOL. 79; NO 1; PP. 45-50; BIBL. 14 REF.Article

ACTIVATION OF THE EARLY COMPONENTS OF THE CLASSICAL COMPLEMENT PATHWAY UNDER PHYSIOLOGIC CONDITIONSZICCARDI RJ.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 5; PP. 1769-1773; BIBL. 38 REF.Article

ETUDE DU TAUX NORMAL DU COMPLEMENT DANS UNE POPULATION DE KINSHASA, ZAIRE. INFLUENCE DU SEXE, DE L'AGE ET DES PERIODES DE PRELEVEMENT DES SERUMSMBUYI MUAMBA JM; TSHIANI A; NYOMBA G et al.1980; ANN. SOC. BELGE MED. TROP.; ISSN 0365-6527; BEL; DA. 1980; VOL. 60; NO 4; PP. 387-393; ABS. ENG/FLE; BIBL. 18 REF.Article

DIFFERENTIAL ELUTION OF CLQ, C1Q, C1R AND C1S FROM HUMAN C1 BOUND TO IMMUNE AGGREGATES. USE IN THE RAPID PURIFICATION OF C1 SUBCOMPONENTSARLAUD GJ; SIM RB; DUPLAA AM et al.1979; MOL. IMMUNOL.; GBR; DA. 1979; VOL. 16; NO 7; PP. 445-450; BIBL. 30 REF.Article